Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine

Biochemical and Biophysical Research Communications

Volumn 427, Issue 4, 2012, Pages 796-800

  Rocha Pereira, J ^a   Jochmans, D ^b   Dallmeier, K ^b   Leyssen, P ^b   Cunha, R ^a   Costa, I ^a   Nascimento, M S J ^a   Neyts, J ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

2' C methyl nucleoside analogues; Antiviral activity; Norovirus; RNA dependent RNA polymerase

Indexed keywords

2' METHYLCYTIDINE; RIBAVIRIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; PROGENY; RNA SYNTHESIS; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTIDINE; DRUG RESISTANCE, VIRAL; MICE; NOROVIRUS; RIBAVIRIN; VIRUS REPLICATION;

HEPATITIS C VIRUS; MURINAE; NOROVIRUS; RNA VIRUSES;

EID: 84868214446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.003     Document Type: Article

References (34)

1. Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. N. Engl. J. Med. 2009, 361:1776-1785.
2. Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinje J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 2008, 14:1224-1231.
3. Green K.Y. Caliciviridae: the noroviruses. Fields Virology 2007, 949-979. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
4. Liu B., Clarke I.N., Lambden P.R. Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis. J. Virol. 1996, 70:2605-2610.
5. Pfister T., Wimmer E. Polypeptide p41 of a Norwalk-like virus is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 2001, 75:1611-1619.
6. Fukushi S., Kojima S., Takai R., Hoshino F.B., Oka T., Takeda N., Katayama K., Kageyama T. Poly(A)- and primer-independent RNA polymerase of norovirus. J. Virol. 2004, 78:3889-3896.
7. Rohayem J., Jager K., Robel I., Scheffler U., Temme A., Rudolph W. Characterization of norovirus 3Dpol RNA-dependent RNA polymerase activity and initiation of RNA synthesis. J. Gen. Virol. 2006, 87:2621-2630.
8. Ferrer-Orta C., Arias A., Escarmis C., Verdaguer N. A comparison of viral RNA-dependent RNA polymerases. Curr. Opin. Struct. Biol. 2006, 16:27-34.
9. Ng K.K., Pendas-Franco N., Rojo J., Boga J.A., Machin A., Alonso J.M., Parra F. Crystal structure of norwalk virus polymerase reveals the carboxyl terminus in the active site cleft. J. Biol. Chem. 2004, 279:16638-16645.
10. Hardy M.E. Norovirus protein structure and function. FEMS Microbiol. Lett. 2005, 253:1-8.
11. Duizer E., Schwab K.J., Neill F.H., Atmar R.L., Koopmans M.P., Estes M.K. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 2004, 85:79-87.
12. Chang K.O., Sosnovtsev S.V., Belliot G., King A.D., Green K.Y. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 2006, 353:463-473.
13. Wobus C.E., Karst S.M., Thackray L.B., Chang K.O., Sosnovtsev S.V., Belliot G., Krug A., Mackenzie J.M., Green K.Y., Virgin H.W. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2004, 2:e432.
14. Zeitler C.E., Estes M.K., Venkataram Prasad B.V. X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J. Virol. 2006, 80:5050-5058.
15. Chang K.O., George D.W. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J. Virol. 2007, 81:12111-12118.
16. Rocha-Pereira J., Cunha R., Pinto D.C.G.A., Silva A.M.S., Nascimento M.S.J. (E)-2-Styrylchromones as potential anti-norovirus agents. Bioorg. Med. Chem. 2010, 18:4195-4201.
17. Rocha-Pereira J., Jochmans D., Dallmeier K., Leyssen P., Nascimento M.S., Neyts J. Favipiravir (T-705) inhibits in vitro norovirus replication. Biochem. Biophys. Res. Commun. 2012, 424:777-780.
18. De Palma A.M., Vliegen I., De Clercq E., Neyts J. Selective inhibitors of picornavirus replication. Med. Res. Rev. 2008, 28:823-884.
19. Alen M.M., Kaptein S.J., De Burghgraeve T., Balzarini J., Neyts J., Schols D. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology 2009, 387:67-75.
20. De Palma A.M., Purstinger G., Wimmer E., Patick A.K., Andries K., Rombaut B., De Clercq E., Neyts J. Potential use of antiviral agents in polio eradication. Emerg. Infect. Dis. 2008, 14:545-551.
21. Leyssen P., Balzarini J., De Clercq E., Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol. 2005, 79:1943-1947.
22. Paeshuyse J., Vliegen I., Coelmont L., Leyssen P., Tabarrini O., Herdewijn P., Mittendorfer H., Easmon J., Cecchetti V., Bartenschlager R., Puerstinger G., Neyts J. Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors. Antimicrob. Agents Chemother. 2008, 52:3433-3437.
23. Baert L., Wobus C.E., Van Coillie E., Thackray L.B., Debevere J., Uyttendaele M. Detection of murine norovirus 1 by using plaque assay, transfection assay, and real-time reverse transcription-PCR before and after heat exposure. Appl. Environ. Microbiol. 2008, 74:543-546.
24. Carroll S.S., Tomassini J.E., Bosserman M., Getty K., Stahlhut M.W., Eldrup A.B., Bhat B., Hall D., Simcoe A.L., LaFemina R., Rutkowski C.A., Wolanski B., Yang Z., Migliaccio G., De Francesco R., Kuo L.C., MacCoss M., Olsen D.B. Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs. J. Biol. Chem. 2003, 278:11979-11984.
25. Goris N., De Palma A., Toussaint J.F., Musch I., Neyts J., De Clercq K. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus. Antiviral Res. 2007, 73:161-168.
26. Pierra C., Amador A., Benzaria S., Cretton-Scott E., D'Amours M., Mao J., Mathieu S., Moussa A., Bridges E.G., Standring D.N., Sommadossi J.P., Storer R., Gosselin G. Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine. J. Med. Chem. 2006, 49:6614-6620.
27. Afdhal N., O'Brien C., Godofsky E., Rodriguez-Torres M., Pappas S.C., Pockros P., Lawitz E., Bzowej N., Rustgi V., Sulkowski M., Sherman K., Jacobson I., Chao G., Knox S., Pietropaolo K., Brown N. 39 Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegIFN/RBV) re-treatment in hepatitis patients with prior non-response to PEGIFN/RBV: week 24 results. J. Hepatol. 2006, 44(Suppl. 2):S19.
28. Afdhal N., O'Brien C., Godofsky E., Rodriguez-Torres M., Pappas S.C., Lawitz E., Pockros P., Sulkowski M., Jacobson I., Chao G., Knox S., Pietropaolo K., Brown N.A. [6] Valopicitabine (NM283), alone or with peg-interferon, compared to peg interferon/ribavirin (pegIFN/RBV) retreatment in patients with hcv-1 infection and prior non-response to pegIFN/RBV: one-year results. J. Hepatol. 2007, 46(Suppl. 1):S5.
29. Costantini V.P., Whitaker T., Barclay L., Lee D., McBrayer T.R., Schinazi R.F., Vinje J. Antiviral activity of nucleoside analogues against norovirus. Antivir. Ther. 2012.
30. Tomassini J.E., Getty K., Stahlhut M.W., Shim S., Bhat B., Eldrup A.B., Prakash T.P., Carroll S.S., Flores O., MacCoss M., McMasters D.R., Migliaccio G., Olsen D.B. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells. Antimicrob. Agents Chemother. 2005, 49:2050-2058.
31. Migliaccio G., Tomassini J.E., Carroll S.S., Tomei L., Altamura S., Bhat B., Bartholomew L., Bosserman M.R., Ceccacci A., Colwell L.F., Cortese R., De Francesco R., Eldrup A.B., Getty K.L., Hou X.S., LaFemina R.L., Ludmerer S.W., MacCoss M., McMasters D.R., Stahlhut M.W., Olsen D.B., Hazuda D.J., Flores O.A. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 2003, 278:49164-49170.
32. Delang L., Vliegen I., Froeyen M., Neyts J. Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication. Antimicrob. Agents Chemother. 2011, 55:4103-4113.
33. Coelmont L., Paeshuyse J., Windisch M.P., De Clercq E., Bartenschlager R., Neyts J. Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2'-C-methylcytidine, the active component of valopicitabine. Antimicrob. Agents Chemother. 2006, 50:3444-3446.
34. Thibaut H.J., Leyssen P., Puerstinger G., Muigg A., Neyts J., De Palma A.M. Towards the design of combination therapy for the treatment of enterovirus infections. Antiviral Res. 2011, 90:213-217.